Pulmonology Medical News about Asthma Formoterol

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cochrane Reviews, 10/19/09

Cates CJ et al. – This review sought information from trials that compared the two treatments head–to–head. All subjects were prescribed regular background treatment with inhaled corticosteroids. Three trials on 1116 adults and one trial on 156 children were found. There is not enough information to draw any conclusions on the relative safety of regular formoterol and regular salmeterol in chronic asthma, but serious asthma–related events were rare, and only one non–asthma–related death was reported.

<< Previous
Risk Factors for Lower Respiratory Tract Infection Death Among...

Next >>
Systematic Review and Metaanalysis:Urinary Antigen Tests for...